The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients

British Journal of Haematology

Volumn 106, Issue 3, 1999, Pages 737-743

  Mitterer, Manfred ^a,c   Oduncu, F ^b   Lanthaler, A J ^a   Drexler, E ^b   Amaddii, G ^a   Fabris, P ^a   Emmerich, B ^b   Coser, P ^a   Straka, C ^b  

^a Department of Haematology   (Italy)

^b UNIVERSITY OF MUNICH   (Germany)

^c Dept of Haematol and Bone M ^*  (Italy)

Author keywords

Double stern cell transplant; High dose chemotherapy; Multiple myeloma; Negative selection; Purging

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; VINCRISTINE;

ADULT; APHERESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MULTIPLE MYELOMA; PRE B LYMPHOCYTE; PRIORITY JOURNAL;

ADULT; B-LYMPHOCYTES; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PLASMA CELLS; TREATMENT OUTCOME;

EID: 0032869589     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01603.x     Document Type: Article

References (35)

1. Anderson, K.C., Barut, B.A., Ritz, J., Freedman, A.S., Takvorian, T., Rabinowe, S.N., Soiffer, R., Hefin, L., Coral, F., Dear, K., Mauch, P. & Nadler, L.M. (1991) Monoclonal antibody purged autologous bone marrow transplantation therapy for multiple myeloma. Blood, 77, 712-720.
2. Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Cassassus, P., Maissonneuve, H., Facon, T., Ifrah, N., Payen., C. & Bataille, R. (1996) A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 91-97.
3. Barlogie, B., Jagganath, S., Vesole, D.H., Naucke, S., Cheson, B., Mattox, S., Bracy, D., Salmon, S., Jacobson, J., Crowley, J. & Tricot, G. (1997) Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood, 89, 789-793.
4. + peripheral blood cells expressing CD38, CD56 and monotypic immunoglobulin light chain. Blood, 85, 436-447.
5. Billadeau, D., Quam, L., Thomas, W., Kay, N., Greipp, P., Kyle, R., Oken, M. & Van Ness, B. (1992) Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood, 80, 1818-1824.
6. Billadeau, D., van Ness, B., Kimlinger, T., Kyle, R.A., Therneau, T.M., Greipp, P.R. & Witzig, T.E. (1996) Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering myeloma and active myeloma. Blood, 88, 289-296.
7. Blade, J., Samson, D., Reece, D., Apperley, J., Bjorkstrand, B., Gahrton, G., Gertz, M., Giralt, S., Jagannath, S. & Vesole, D. (1998) Criteria for evluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. British Journal of Haematology, 102, 1115-1125.
8. Brenner, M.K., Rill, D.R., Moen, R.C., Krance, R.A., Mirro, J., Jr, Anderson, W.F. & Ihle, J.N. (1993) Gene marking to trace the origin of relapse after autologous bone marrow transplantation. Lancet, 341, 85-86.
9. Chen, B. & Epstein, J. (1996) Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood, 87, 1972-1974.
10. Corradini, P., Voena, C., Astolfi, M., Ladetto, M., Tarrella, C., Boccadoro, M. & Pileri, A. (1995) High dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvest and after autografting. Blood, 85, 1596-1602.
11. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83, 3068-3076.
12. 1 stem cells do not contain clonal myeloma cells. Blood, 86, 381-389.
13. Gertz, M.A., Witzig, T.E., Pineda, A.A., Greipp, P.R., Kyle, R.A. & Litzow, M.R. (1997) Monoclonal plasmacells in the peripheral blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse free survival after transplantation. Bone Marrow Transplantation, 19, 337-342.
14. Gribben, J.G., Freedman, A.S., Neuberg, D., Roy, D.C., Blake, K.W., Woo, S.D., Grossbard, M.L., Rabinove, S.N., Coral, F. & Freeman, G.J. (1991) Immunological purging of bone marrow assessed by PCR before autologous transplantation for B-cell lymphoma. New England Journal of Medicine, 325, 1525-1533.
15. Jensen, G.S., Belch, A.R., Mant, M.J., Ruether, B.A., Yacyshyn, B.R. & Pilarski, L.M. (1993) Expression of multiple beta 1 integrins on circulating monoclonal B-cells in patients with multiple myeloma. American Journal of Hematology, 43, 29-36.
16. Kimlinger, T. & Witzig, T.E. (1997) Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma. Bone Marrow Transplantion, 19, 553-556.
17. Massellis Smith, A., Belch, A.R., Mant, M.J., Turley, E.A. & Pilarski, L.M. (1996) Hyaluronan dependent motility of B-cells and leukemic plasma cells but not of bone marrow plasma cells in multiple myeloma: alternate usage of RHAMM and CD44. Blood, 87, 1891-1899.
18. Mitterer, M., Hirber, J., Gentilini, I., Prinoth, O., Fabris, P., Emmerich, B., Coser, P. & Straka, C. (1996) Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high dose chemotherapy and rh G-CSF. Bone Marrow Transplantation, 18, 611-617.
19. Owen, R.G., Johnson, R.J., Rawstron, A.C., Evans, P.A., Jack, A., Smith, G.M., Child, J.A. & Morgan, G.J. (1996) Assessment of IgH PCR strategies in multiple myeloma. Journal of Clinical Pathology, 49, 672-675.
20. Pilarski, L.M. & Belch, A.R. (1994) Circulating monoclonal B-cells expressing P glycoprotein may be a reservoir of multidrug resistant disease in multiple myeloma. Blood, 83, 724-736.
21. Pilarski, L.M., Masellis Smith, A., Belch, A.R., Yang, B., Savani, R.C. & Turley, E.A. (1994) RHAMM, a receptor for hyaluronan mediated motility, on normal lymphocytes, thymocytes and in B-cell malignancy: a mediator in B-cell malignancy? Leukemia and Lymphoma, 14, 363-374.
22. Pilarski, L.M., Masellis Smith, A., Szczepek, A., Mant, M.J. & Belch, A.R. (1996) Circulating clonotypic B-cells in the biology of myeloma: speculations on the origin of multiple myeloma. Leukemia and Lymphoma, 22, 375-383.
23. Rill, D.R., Santana, V.M., Roberts, W.M., Nilson, T., Bowman, L.C., Krance, R.A., Heslop, H.E., Moen, R.C., Ihle, J.N. & Brenner, M.K. (1994) Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood, 84, 380-383.
24. Rhodes, E.G.H., Baker, P.K., Rhodes, J.M., Davies, J.M. & Duguid, J.K.M. (1994) Autologous bone marrow transplantation for myeloma patients using PNA and CD19 purged marrow rescue. Bone Marrow Transplantation, 13, 795-799.
25. San Miguel, J., Garcia Sanz, G., Gonzales, M. & Orfao, A. (1995) Immunophenotype and DNA cell content in multiple myeloma. Ballieres Clinical Haematology, 8, 735-759.
26. Shiach, C.R., Evans, P.A.S., Short, M.A., Bailey, C.C., Lewis, I.J. & Kinsey, S.E. (1993) Detection and accurate sizing of PCR product by automated scanning: improved detection of immunoglobulin gene rearrangement in ALL. British Journal of Hematology, 85, 431-432.
27. Schiller, G., Vescio, R., Freytes, C., Spitzer, G., Sahebi, F., Lee, M., Hua Wu, C., Cao, J., Lee, J.C., Hong, C.H., Lichtenstein, A., Lill, M., Hall, J., Berenson, R. & Berenson, J. (1995) Transplantation of CD 34 peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma. Blood, 86, 390-397.
28. Seiden, M.V., Schlossman, R., Anderson, J., Freeman, A., Robertson, M., Soiffer, R., Freedman, A., Mauch, P., Ritz, J., Nadler, L. & Anderson, K.C. (1995) Monoclonal antibody purged bone marrow transplantation therapy for multiple myeloma. Leukemia and Lymphoma, 17, 87-93.
29. Straka, C., Pettengell, R., Pielmeier, A., Cross, M., Emmerich, B., Crowther, D., Testa, N.G. & Dexter, T.M. (1994) A reliable approach for sequencing clone specific CDRIII regions in B-cell lymphoma. Annals of Oncology, 5, 79-84.
30. Vescio, R.A., Hong, C.H., Cao, J., Kim, A., Schiller, G.J., Lichtenstein, A.K., Berenson, R.J. & Berenson, J.R. (1994) The hematopoietic stem cell antigen CD34 is not expressed on the malignant cells in multiple myeloma. Blood, 84, 3283-3290.
31. Warburton, P., Joshua, D.E., Gibson, J. & Brown, R.D. (1989) CD10-(CALLA) positive lymphocytes in myeloma: evidence that they are a malignant precursor population and are of germinal centre origin. Leukemia and Lymphoma, 1, 11-20.
32. + myeloma cells. British Journal of Haematalogy, 93, 613-622.
33. Witzig, T.E., Dhodapkar, M.V., Kyle, R.A. & Greipp, P.R. (1993) Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer, 72, 108-113.
34. Witzig, T.E., Gertz, M.A., Lust, J.A., Kyle, R.A., O'Fallon, W.M. & Greipp, P.R. (1996) Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood, 88, 1780-1787.
35. Witzig, T.E., Gertz, M.A., Pineda, A.A., Kyle, R.A. & Greipp, P.R. (1995) Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma. British Journal of Haematology, 89, 640-642.